Global C Difficile Infection Drug Market Status and Outlook 2018-2025

August 2018 | 149 pages | ID: G1D48BA73C4EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Merck
• Astellas
• Eli Lilly
• ANI Pharmaceutical
• Flynn Pharma
• Aspen Pharmacare
• Akorn
• Merus labs
• Pfizer
• AstraZeneca
• Strides
• Sanofi
• Fresenius
• Xellia
• Zhejiang Medicine
• Lupin

Market by Type

• Metronidazole
• Vancomycin
• Fidaxomycin
• Others

Market by Application

• Pre-treatment
• Mid-term treatment
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 C Difficile Infection Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Metronidazole
  3.1.2 Vancomycin
  3.1.3 Fidaxomycin
  3.1.4 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Pre-treatment
  4.1.2 Mid-term treatment
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Metronidazole Production by Region
    6.1.1.2 Vancomycin Production by Region
    6.1.1.3 Fidaxomycin Production by Region
    6.1.1.4 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Pre-treatment Production by Region
    6.1.2.2 Mid-term treatment Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Metronidazole Demand by Region
    6.2.1.2 Vancomycin Demand by Region
    6.2.1.3 Fidaxomycin Demand by Region
    6.2.1.4 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Pre-treatment Demand by Region
    6.2.2.2 Mid-term treatment Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Merck
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Astellas
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Eli Lilly
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 ANI Pharmaceutical
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Flynn Pharma
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Aspen Pharmacare
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Akorn
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Merus labs
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Pfizer
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 AstraZeneca
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Strides
8.12 Sanofi
8.13 Fresenius
8.14 Xellia
8.15 Zhejiang Medicine
8.16 Lupin

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table C Difficile Infection Drug Industry Dynamics & Regulations List
Table Global C Difficile Infection Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global C Difficile Infection Drug Market Status by Type 2015-2018E, in USD Million
Table Global C Difficile Infection Drug Market Status by Application 2015-2018E, in USD Million
Table Global C Difficile Infection Drug Market Status by Application 2015-2018E, in Volume
Table Global C Difficile Infection Drug Market by Region 2015-2018E, in USD Million
Table Global C Difficile Infection Drug Market Share by Region in 2018, in USD Million
Table Global C Difficile Infection Drug Market by Region 2015-2018E, in Volume
Table Global C Difficile Infection Drug Market Share by Region in 2018, in Volume
Table Metronidazole Production Value by Region 2015-2018E, in USD Million
Table Metronidazole Production Volume by Region 2015-2018E, in Volume
Table Vancomycin Production Value by Region 2015-2018E, in USD Million
Table Vancomycin Production Volume by Region 2015-2018E, in Volume
Table Fidaxomycin Production Value by Region 2015-2018E, in USD Million
Table Fidaxomycin Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Pre-treatment Production Value by Region 2015-2018E, in USD Million
Table Pre-treatment Production Volume by Region 2015-2018E, in Volume
Table Mid-term treatment Production Value by Region 2015-2018E, in USD Million
Table Mid-term treatment Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Metronidazole Market Size by Region 2015-2018E, in USD Million
Table Metronidazole Market Size by Region 2015-2018E, in Volume
Table Vancomycin Market Size by Region 2015-2018E, in USD Million
Table Vancomycin Market Size by Region 2015-2018E, in Volume
Table Fidaxomycin Market Size by Region 2015-2018E, in USD Million
Table Fidaxomycin Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Pre-treatment Market Size by Region 2015-2018E, in USD Million
Table Pre-treatment Market Size by Region 2015-2018E, in Volume
Table Mid-term treatment Market Size by Region 2015-2018E, in USD Million
Table Mid-term treatment Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalC Difficile Infection Drug Forecast by Type 2019F-2025F, in USD Million
Table C Difficile Infection Drug Forecast by Type 2019F-2025F, in Volume
Table C Difficile Infection Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table C Difficile Infection Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table C Difficile Infection Drug Market Forecast by Region 2019F-2025F, in USD Million
Table C Difficile Infection Drug Market Forecast by Region 2019F-2025F, in Volume
Table Merck Information
Table C Difficile Infection Drug Sales, Cost, Margin of Merck
Table Astellas Information
Table C Difficile Infection Drug Sales, Cost, Margin of Astellas
Table Eli Lilly Information
Table C Difficile Infection Drug Sales, Cost, Margin of Eli Lilly
Table ANI Pharmaceutical Information
Table C Difficile Infection Drug Sales, Cost, Margin of ANI Pharmaceutical
Table Flynn Pharma Information
Table C Difficile Infection Drug Sales, Cost, Margin of Flynn Pharma
Table Aspen Pharmacare Information
Table C Difficile Infection Drug Sales, Cost, Margin of Aspen Pharmacare
Table Akorn Information
Table C Difficile Infection Drug Sales, Cost, Margin of Akorn
Table Merus labs Information
Table C Difficile Infection Drug Sales, Cost, Margin of Merus labs
Table Pfizer Information
Table C Difficile Infection Drug Sales, Cost, Margin of Pfizer
Table AstraZeneca Information
Table C Difficile Infection Drug Sales, Cost, Margin of AstraZeneca
Table Strides Information
Table C Difficile Infection Drug Sales, Cost, Margin of Strides
Table Sanofi Information
Table C Difficile Infection Drug Sales, Cost, Margin of Sanofi
Table Fresenius Information
Table C Difficile Infection Drug Sales, Cost, Margin of Fresenius
Table Xellia Information
Table C Difficile Infection Drug Sales, Cost, Margin of Xellia
Table Zhejiang Medicine Information
Table C Difficile Infection Drug Sales, Cost, Margin of Zhejiang Medicine
Table Lupin Information
Table C Difficile Infection Drug Sales, Cost, Margin of Lupin
Table Global C Difficile Infection Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global C Difficile Infection Drug Sales Volume by Company 2015-2017, in Volume
Table Global C Difficile Infection Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure C Difficile Infection Drug Picture
Figure C Difficile Infection Drug Industry Chain Diagram
Figure Global C Difficile Infection Drug Sales Revenue 2015-2018E, in USD Million
Figure Global C Difficile Infection Drug Sales Volume 2015-2018E, in Volume
Figure Global C Difficile Infection Drug Market Status by Type 2015-2018E, in Volume
Figure North America C Difficile Infection Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America C Difficile Infection Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe C Difficile Infection Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe C Difficile Infection Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific C Difficile Infection Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific C Difficile Infection Drug Market Size and Growth 2015-2018E, in Volume
Figure South America C Difficile Infection Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America C Difficile Infection Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East C Difficile Infection Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East C Difficile Infection Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa C Difficile Infection Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa C Difficile Infection Drug Market Size and Growth 2015-2018E, in Volume
Figure Global C Difficile Infection Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global C Difficile Infection Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global C Difficile Infection Drug Sales Price Forecast 2019F-2025F
Figure Global C Difficile Infection Drug Gross Margin Forecast 2019F-2025F
Figure Global C Difficile Infection Drug Sales Revenue by Company in 2018, in USD Million
Figure Global C Difficile Infection Drug Price by Company in 2018
Figure Global C Difficile Infection Drug Gross Margin by Company in 2018